August 5, 2025
Dr. Eric Forister’s Analysis Cited in Innovative Health v. Biosense Webster Injunction
On July 31, 2025, following a $147 million jury verdict trebled to $442 million plus costs, the U.S. District Court for the Central District of California granted Innovative Health’s motion for permanent injunctive relief against Biosense Webster. Dr. Eric Forister provided economic analysis demonstrating that three actions of Biosense were anticompetitive: (1) a “case coverage policy” tying clinical support and catheters, (2) deliberate deployment of “Falcon” blocking chips to prevent reprocessing of catheters, and (3) hoarding of used catheters suppressed reprocessor competition without improving product quality. The court granted a ten-year permanent injunction on all three of these actions. The case is Innovative Health LLC v. Biosense Webster, Inc., Case No. 8:19-cv-01984-JVS-KES (C.D. Cal.)
